You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HAART suppressed

Showing 1 - 25 of 828
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Denver (Raltegravir)

Completed
  • HIV
  • Denver, Colorado
    National Jewish Health
Jan 15, 2021

HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)

Withdrawn
  • HIV Infections
  • GEO-D03 DNA Vaccine
  • +3 more
  • (no location specified)
Nov 4, 2021

Low Viral Load on Highly Active Antiretroviral Therapy (HAART)

Completed
  • HIV Infections
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 18, 2019

    Human Immunodeficiency Virus Trial in Italy (RPV + DRV/r, continue the PI/r-containing HAART.)

    Completed
    • Human Immunodeficiency Virus
    • RPV + DRV/r
    • continue the PI/r-containing HAART.
    • Bari, BA, Italy
    • +11 more
    Mar 31, 2020

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

    Recruiting
    • HIV
    • Leukapheresis
    • San Francisco, California
      San Francisco General Hospital
    Dec 15, 2020

    HIV, AIDS Trial in Baltimore (Tenofovir, Hydroxyurea)

    Completed
    • HIV Infections
    • AIDS
    • Baltimore, Maryland
      University of Maryland, Institute of Human Virology
    May 6, 2021

    Human Immunodeficiency Virus (HIV), HIV Associated Neurocognitive Disorders (HAND) Trial in Sydney, Melbourne (Maraviroc)

    Completed
    Has Results
    • Human Immunodeficiency Virus (HIV)
    • HIV Associated Neurocognitive Disorders (HAND)
    • Sydney, New South Wales, Australia
    • +1 more
    Feb 12, 2019

    Human Immunodeficiency Virus Trial in Oakland Park (bictegravir/emtricitabine/tenofovir alafenamide)

    Completed
    • Human Immunodeficiency Virus
    • bictegravir/emtricitabine/tenofovir alafenamide
    • Oakland Park, Florida
      Midland Research Group, Inc
    Feb 23, 2021

    HIV, Antiretroviral Therapy Trial in New York (Heart to Heart)

    Completed
    • HIV
    • Antiretroviral Therapy
    • Heart to Heart
    • New York, New York
      New York University College of Nursing
    Oct 31, 2022

    HIV-1-infection Trial in Nairobi

    Recruiting
    • HIV-1-infection
      • Nairobi, Kenya
        Kenya Medical Research Institute
      Jul 19, 2021

      HIV Trial (Low dose KL-HIV-Tri01, Middle dose KL-HIV-Tri01, High dose KL-HIV-Tri01)

      Not yet recruiting
      • HIV Infections
      • Low dose KL-HIV-Tri01
      • +2 more
      • (no location specified)
      Nov 5, 2023

      HIV-1 Infection Trial in San Francisco, Baltimore (Disulfiram)

      Completed
      Has Results
      • HIV-1 Infection
      • San Francisco, California
      • +1 more
      Jun 29, 2020

      Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

      Not yet recruiting
      • Chronic Hepatitis B
      • HRS9950 tablets
      • HRS9950 placebo tablets
      • (no location specified)
      Jun 7, 2023

      HIV-1-infection Trial (B/F/TAF)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Oct 23, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • (no location specified)
      Jun 11, 2023

      HIV Trial in Cleveland (tocilizumab, Placebo)

      Completed
      Has Results
      • HIV Infections
      • Cleveland, Ohio
        Case Clinical Research Site
      Dec 15, 2020

      HIV-1-infection Trial (Bictegravir, Lenacapavir, BIC/LEN FDC)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Aug 12, 2022

      HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

      Recruiting
      • HIV-1-infection
      • San Francisco, California
      • +6 more
      Oct 25, 2022

      HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

      Not yet recruiting
      • HIV Infections
      • Teropavimab
      • +4 more
      • (no location specified)
      Feb 6, 2023

      Leukapheresis Procedures to Obtain Plasma and Lymphocytes for

      Recruiting
      • HIV
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 7, 2023

        HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

        Not yet recruiting
        • HIV Infections
        • VH3810109
        • +3 more
        • Birmingham, Alabama
        • +42 more
        Aug 9, 2023

        HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

        Active, not recruiting
        • HIV I Infection
        • Dolutegravir / Lamivudine Pill
        • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
        • Orlando, Florida
          Orlando Immunology Center
        Sep 20, 2022

        HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

        Not yet recruiting
        • HIV-1-infection
        • Once daily CAB tablet + RPV tablet
        • Long acting CAB injectable + long acting RPV injectable
        • Atlanta, Georgia
        • +11 more
        Dec 13, 2022

        HIV, Bariatric Surgery Candidate Trial (bariatric surgery)

        Not yet recruiting
        • HIV Infections
        • Bariatric Surgery Candidate
        • bariatric surgery
        • (no location specified)
        Sep 9, 2022

        Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

        Recruiting
        • Triple-Negative Breast Cancer
        • Shanghai, Shanghai, China
          Breast cancer institute of Fudan University Cancer Hospital
        Mar 28, 2023